Krishna Institute of Medical Sciences Ltd

Krishna Institu. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Krishna Institute of Medical Sciences Ltd

₹ 737 -1.13%
28 Aug - close price
kimshospitals.com BSE: 543308 NSE: KIMS
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]

Website BSE NSE
  • Market Cap ₹ 29,510 Cr.
  • Current Price ₹ 737
  • High / Low ₹ 798 / 474
  • Stock P/E 101
  • Book Value ₹ 54.2
  • Dividend Yield 0.00 %
  • ROCE 16.0 %
  • ROE 14.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 13.6 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -4.71%
  • The company has delivered a poor sales growth of 11.9% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
263 292 284 293 299 316 302 305 327 363 348 346 373
185 204 194 189 207 218 215 218 234 252 245 237 276
Operating Profit 78 88 90 104 92 98 87 86 94 111 103 109 98
OPM % 30% 30% 32% 36% 31% 31% 29% 28% 29% 31% 30% 31% 26%
4 8 7 4 4 4 4 4 5 7 21 35 12
Interest 0 0 0 0 0 0 1 2 4 5 7 8 12
Depreciation 11 11 11 11 12 13 13 20 14 14 15 15 18
Profit before tax 70 84 86 97 84 89 78 68 82 99 102 120 80
Tax % 26% 27% 25% 24% 25% 26% 25% 29% 26% 27% 25% 22% 26%
52 61 64 74 63 66 58 48 61 72 76 94 59
EPS in Rs 1.30 1.53 1.61 1.84 1.56 1.65 1.46 1.20 1.52 1.80 1.91 2.34 1.47
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
485 536 628 707 790 933 1,143 1,132 1,222 1,384 1,430
380 422 562 652 584 624 740 768 857 963 1,010
Operating Profit 104 114 66 55 206 309 403 364 366 421 420
OPM % 22% 21% 10% 8% 26% 33% 35% 32% 30% 30% 29%
4 3 3 6 7 8 21 23 18 68 74
Interest 36 32 88 33 24 18 9 5 7 28 32
Depreciation 34 34 38 41 43 45 45 45 58 58 62
Profit before tax 38 51 -57 -13 147 254 371 337 318 403 401
Tax % 37% 37% 43% 225% 17% 26% 25% 25% 26% 25%
24 33 -81 -44 121 189 278 252 235 303 301
EPS in Rs 0.69 0.91 -2.27 -1.17 3.25 4.86 6.96 6.31 5.88 7.57 7.52
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 7%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 18%
3 Years: 0%
TTM: 25%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 46%
1 Year: 47%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 15%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 70 72 50 74 74 78 80 80 80 80
Reserves 191 252 -249 429 550 830 1,298 1,551 1,786 2,088
251 277 666 187 186 131 18 4 326 708
134 153 323 166 147 175 173 177 204 313
Total Liabilities 646 753 789 857 957 1,214 1,569 1,812 2,397 3,189
498 501 576 567 559 582 592 612 674 773
CWIP 2 64 0 0 2 8 13 16 292 530
Investments 18 22 31 80 178 213 542 826 1,062 1,226
128 167 182 210 218 411 422 358 368 660
Total Assets 646 753 789 857 957 1,214 1,569 1,812 2,397 3,189

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
89 78 94 109 161 291 284 271 262 294
-39 -99 -52 -99 -108 -317 -375 -238 -569 -627
-61 25 -42 -12 -24 25 76 -15 289 339
Net Cash Flow -10 5 0 -2 28 0 -15 18 -18 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 46 59 56 52 46 29 28 39 44 49
Inventory Days 35 43 39 42 44 30 38
Days Payable 192 205 189 161 158 155 118
Cash Conversion Cycle -111 -103 -94 -68 -68 -96 -52 39 44 49
Working Capital Days 11 26 -72 2 -4 -29 6 12 3 -23
ROCE % 15% 6% 3% 23% 30% 31% 23% 17% 16%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
38.85% 38.85% 38.85% 38.85% 38.85% 38.82% 38.82% 38.82% 38.82% 38.82% 38.82% 34.11%
10.17% 20.50% 19.41% 13.15% 14.24% 15.27% 16.73% 17.84% 15.85% 15.68% 15.44% 15.54%
27.97% 28.32% 29.76% 35.77% 34.80% 34.24% 33.13% 32.12% 32.29% 32.05% 31.95% 31.65%
23.01% 12.34% 11.99% 12.23% 12.10% 11.67% 11.32% 11.22% 13.03% 13.45% 13.78% 18.68%
No. of Shareholders 67,73563,36260,98065,44966,95771,01469,09269,06377,61795,4681,01,8951,08,955

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls